Nasdaq Supn News Today

Mach 1 Financial Group LLC purchased a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 14,554 shares of the specialty pharmaceutical company’s stock, valued at approximately $421,000. A number of other institutional […]

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) VP Padmanabh P. Bhatt sold 14,491 shares of the company’s stock in a transaction dated Thursday, March 21st. The stock was sold at an average price of $35.31, for a total value of $511,677.21. Following the transaction, the vice president now directly owns 8,570 shares of the […]

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) VP Padmanabh P. Bhatt sold 14,491 shares of the firm’s stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $35.31, for a total transaction of $511,677.21. Following the transaction, the vice president now directly owns 8,570 shares […]

Polar Capital Holdings Plc raised its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 10.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,654,470 shares of the specialty pharmaceutical company’s stock after acquiring an additional 150,000 […]

ROCKVILLE, Md., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

Congress Asset Management Co. MA boosted its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 19.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 917,164 shares of the specialty pharmaceutical company’s stock after buying an additional 147,105 shares during the […]

Campbell Newman Asset Management Inc. raised its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 63.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,355 shares of the specialty pharmaceutical company’s stock after purchasing an additional 16,476 shares during the quarter. Campbell […]

Legato Capital Management LLC decreased its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 3.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,472 shares of the specialty pharmaceutical company’s stock after selling 837 shares during […]

StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a report released on Wednesday. Separately, Piper Sandler raised their price target on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a research report on Thursday, November 9th. […]

StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a research report released on Saturday. Separately, Piper Sandler increased their target price on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the stock an overweight rating in a report on Thursday, November 9th. […]